Cite

HARVARD Citation

    Chen, L. et al. (2021). Long-term oral administration of hyperoside ameliorates AD-related neuropathology and improves cognitive impairment in APP/PS1 transgenic mice. Neurochemistry international. p. . [Online]. 
  
Back to record